Literature DB >> 6617080

The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).

M H Bennett, K A MacLennan, M J Easterling, B Vaughan Hudson, A M Jelliffe, G Vaughan Hudson.   

Abstract

A histological review of 271 cases of nodular sclerosing Hodgkin's disease, patients presenting with clinical Stage I, II and III disease but not subjected to a staging laparotomy, has been undertaken. Cases were categorised according to the cytological appearances of the cellular nodules and the degree of sclerosis was examined. Cytological subtypes with extensive and easily recognised areas of lymphocyte depletion or numerous pleomorphic Hodgkin's cells were associated with a decreased survival and clinical stage did not appear to be a good indicator of prognosis in these patients. Pronounced nodal sclerosis was associated with a higher relative frequency of mediastinal disease and the lymphocyte-depleted cytological subtypes.

Entities:  

Mesh:

Year:  1983        PMID: 6617080     DOI: 10.1016/s0009-9260(83)80148-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  13 in total

1.  Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma.

Authors:  Tarsheen Sethi; Van Nguyen; Shaoying Li; David Morgan; John Greer; Nishitha Reddy
Journal:  Ther Adv Hematol       Date:  2016-10-30

2.  Hodgkin's disease: a flow cytometric study.

Authors:  K G Morgan; P Quirke; C J O'Brien; C C Bird
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

3.  Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.

Authors:  A S Jack; D Cunningham; M Soukop; C N Liddle; F D Lee
Journal:  J Clin Pathol       Date:  1986-03       Impact factor: 3.411

4.  Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.

Authors:  B Vaughan Hudson; D C Linch; E A Macintyre; M H Bennett; K A MacLennan; G Vaughan Hudson; A M Jelliffe
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

5.  Analysis of antigen receptor genes in Hodgkin's disease.

Authors:  C A Angel; J H Pringle; J Naylor; K P West; I Lauder
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

6.  Vimentin expression by Reed-Sternberg cells in Hodgkin's disease.

Authors:  C A Angel; R A Cullen; J H Pringle; I Lauder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 7.  Hodgkin's lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; S Ascani; L Leoncini; E Sabattini; P L Zinzani; P P Piccaluga; A Pileri; M Giunti; B Falini; G B Bolis; H Stein
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

8.  Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patients.

Authors:  M C Trotter; G A Cloud; M Davis; S P Sanford; M M Urist; S J Soong; N B Halpern; W A Maddox; C M Balch
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

9.  Pathobiology of hodgkin lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudio Tripodo; Francesco Bacci; Elena Sabattini; Maria Teresa Sista; Claudia Mannu; Maria Rosaria Sapienza; Maura Rossi; Maria Antonella Laginestra; Carlo A Sagramoso-Sacchetti; Simona Righi; Stefano A Pileri
Journal:  Adv Hematol       Date:  2010-12-22

10.  Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.

Authors:  R García; J M Hernández; M D Caballero; M González; J Galende; M C del Cañizo; L Vázquez; J F San Miguel
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.